COMPANY OVERVIEW

Epirium Bio is a clinical-stage biopharmaceutical company developing therapeutics that promote mitochondrial biogenesis and function through a novel mechanism of action discovered by the company.

---

LOCATION

San Diego, CA, USA

---

THERAPEUTIC AREAS

Aging

---

WEBSITE

https://epirium.com

---

CAREER WEBSITE

None

---

SOCIAL MEDIA

---

INVESTORS

---

---

PRESS RELEASES

Oct 13, 2020

Epirium Bio Appoints Alexander Casdin, Reneo Capital Management Founder, as Chief Financial Officer

Aug 12, 2020

Epirium Bio Announces Commencement of Phase 1 Clinical Trial of EPM-01 in Becker Muscular Dystrophy

Apr 14, 2020

Epirium Bio Receives FDA Orphan-Drug Designation for EB 002 ((+)-Epicatechin) for the Treatment of Duchenne and Becker Muscular Dystrophy

Feb 25, 2020

Epirium Bio Appoints Longitude Capital Senior Investment Professional Cristina Ghenoiu, Ph.D., as Senior Vice President of Research and Development Operations and New Product Planning

Feb 4, 2020

Epirium Bio Appoints Former BioMarin Program Lead Ransi Somaratne, M.D., As Chief Medical Officer

For More Press Releases

---